Nguyen, Vi http://orcid.org/0000-0003-4363-5009
Winograd, Joshua
Codelia-Anjum, Alia J.
Zorn, Kevin C.
Elterman, Dean
Bhojani, Naeem
Bechis, Seth K.
Chughtai, Bilal
Article History
Received: 7 February 2024
Accepted: 16 April 2024
First Online: 21 June 2024
Declarations
:
: Dr. Nguyen has no disclosures. Mr. Winograd has no disclosures. Ms. Codelia-Anjum has no disclosures. Dr. Zorn has the following to disclose: Boston Scientific – Consultant, proctor and Procept BioRobotics – Consultant, proctor. Dr. Elterman has the following to disclose: Boston Scientific – Consultant, Procept BioRobotics – Consultant. Olympus – Consultant. Zenflow – Investigator. Dr. Bhojani has the following to disclose: Boston Scientific – Consultant, Procept BioRobotics – Consultant, Olympus – Consultant. Dr. Bechis has the following to disclose: Boston Scientific – Consultant. Dr. Chughtai has the following to disclose: Boston Scientific – Consultant, Olympus – Consultant.
: Institutional Review Board approval was obtained (IRB #20–02021474).
: Informed consent was obtained from all participants.
: This study received support from Boston Scientific Corporation.